Cardiac Function in Children and Young Adults Treated with MEK Inhibitors: A Retrospective Cohort Study
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Pediatrics, Perinatology and Child Health
Link
https://link.springer.com/content/pdf/10.1007/s00246-022-02842-y.pdf
Reference27 articles.
1. Garcia MA, Solomon DA, Haas-Kogan DA (2016) Exploiting molecular biology for diagnosis and targeted management of pediatric low-grade gliomas. Future Oncol 12:1493–1506. https://doi.org/10.2217/fon-2016-0039
2. Walker JA, Upadhyaya M (2018) Emerging therapeutic targets for neurofibromatosis type 1. Expert Opin Ther Targets 22:419–437. https://doi.org/10.1080/14728222.2018.1465931
3. Dombi E, Baldwin A, Marcus LJ et al (2016) Activity of selumetinib in neurofibromatosis type 1–related plexiform neurofibromas. N Engl J Med 375:2550–2560. https://doi.org/10.1056/NEJMoa1605943
4. Banerjee A, Jakacki RI, Onar-Thomas A et al (2017) A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study. Neuro-Oncol 19:1135–1144. https://doi.org/10.1093/neuonc/now282
5. Fangusaro J, Onar-Thomas A, Young Poussaint T et al (2019) Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial. Lancet Oncol 20:1011–1022. https://doi.org/10.1016/S1470-2045(19)30277-3
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3